EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case–Control Study

Sabina Cauci, Cinzia Buligan, Patrizia Nacci, Gianluca Petris, Giuseppe Stinco iD

Current Oncology · 2026

DOI: 10.3390/curroncol33070436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2026. Verfasst von Sabina Cauci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Udine, Piazzale Kolbe 4, 33100 Udine, Italy. Hauptthemen laut MEDLINE: Melanoma, Interleukin-1beta, Skin Neoplasms, Promoter Regions, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Udine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunity plays critical roles in cutaneous melanoma. We investigated the association between the pro-inflammatory interleukin-1β gene (IL-1B) rs16944 (-511 C > T) promoter single nucleotide polymorphism (SNP) and cutaneous melanoma susceptibility and clinical features. This observational case–control study included 133 patients with cutaneous melanoma and 900 healthy controls from Northeastern Italy. The rs16944 C > T polymorphism was determined by genomic DNA restriction fragment analysis. The IL-1B rs16944 C allele (OR = 1.44, p = 0.014) and CC genotype (OR = 1.48, p = 0.037) were associated with modestly higher odds of melanoma. Among melanoma patients, the CC genotype was associated with Stage I disease (OR = 2.45, p = 0.016) and Breslow thickness ≤ 0.75 mm (OR = 2.27, p = 0.049), whereas it was less frequent in Stage IV melanoma (OR = 0.37, p = 0.029). The CT genotype was associated with Stage IV melanoma (OR = 3.03, p = 0.014) and with lower-limb (OR = 2.45, p = 0.038) and lower-extremity (OR = 3.09, p = 0.005) melanoma. These divergent associations are exploratory and do not establish disease trajectory or a functional effect of rs16944; mechanistic interpretation remains uncertain because IL-1β expression or activity was not measured in this cohort. To our knowledge, this is the first report of an association between a genetic polymorphism and lower-limb/lower-extremity melanoma. These exploratory findings require confirmation in independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaInterleukin-1betaSkin NeoplasmsPromoter Regions, GeneticGenetic Predisposition to DiseaseHumansCase-Control StudiesFemaleMalePolymorphism, Single NucleotideMiddle AgedItalyAgedNeoplasm StagingCutaneous Malignant MelanomaAdultGenotype

Stichwörter der Autor:innen

IL-1B gene SNPanti-tumor activitiescancer susceptibilitycytokine IL-1 betagenetic variationinflammationinnate immunitymalignant melanomametastasispromoterskin cancer

Substanzen

Interleukin-1betaIL1B protein, human

Autor:innen und Institutionen

  • Department of Medicine, University of Udine, Piazzale Kolbe 4, 33100 Udine, Italy.
  • Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Santa Maria della Misericordia, Friuli Centrale University Healthcare Hospital of Udine, 33100 Udine, Italy.
  • Fondazione Italiana Fegato ETS-Italian Liver Foundation ETS, 34149 Trieste, Italy.

ORCID-Profile: Giuseppe Stinco

Förderung

  • University of Udine

Zitieren

APA

Cauci, S., Buligan, C., Nacci, P., Petris, G., & Stinco, G. (2026). Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case–Control Study. Current Oncology. https://doi.org/10.3390/curroncol33070436

Vancouver

Cauci S, Buligan C, Nacci P, Petris G, Stinco G. Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case–Control Study. Current Oncology. 2026. doi:10.3390/curroncol33070436

BibTeX
@article{Cauci2026,
  author = {Cauci, Sabina and Buligan, Cinzia and Nacci, Patrizia and Petris, Gianluca and Stinco, Giuseppe},
  title = {Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case–Control Study},
  journal = {Current Oncology},
  year = {2026},
  doi = {10.3390/curroncol33070436}
}
Kostenlos starten →